Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1968 1
1969 2
1970 4
1972 4
1973 2
1975 2
1976 4
1979 2
1980 1
1981 2
1983 3
1984 2
1985 8
1986 7
1987 9
1988 2
1989 5
1990 6
1991 7
1992 12
1993 16
1994 20
1995 13
1996 15
1997 7
1998 12
1999 14
2000 16
2001 29
2002 24
2003 34
2004 57
2005 50
2006 38
2007 23
2008 24
2009 40
2010 37
2011 44
2012 50
2013 45
2014 41
2015 40
2016 32
2017 45
2018 34
2019 40
2020 47
2021 45
2022 46
2023 39
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,035 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for panetta
Search for pantecta instead (1 results)
Reply.
Brough HA, Caubet JC, Mazon A, Haddad D, Bergmann MM, Wassenberg J, Panetta V, Gourgey R, Radulovic S, Nieto M, Santos AF, Nieto A, Lack G, Eigenmann PA. Brough HA, et al. J Allergy Clin Immunol. 2020 May;145(5):1481-1483. doi: 10.1016/j.jaci.2020.02.004. Epub 2020 Mar 26. J Allergy Clin Immunol. 2020. PMID: 32223981 No abstract available.
The four-dimensional Kirschner-Panetta type cancer model: How to obtain tumor eradication?
Krishchenko AP, Starkov KE. Krishchenko AP, et al. Math Biosci Eng. 2018 Oct 1;15(5):1243-1254. doi: 10.3934/mbe.2018057. Math Biosci Eng. 2018. PMID: 30380309 Free article.
This model was elaborated by Arciero et al. and is obtained from the Kirschner-Panetta type model by introducing two various treatments. We provide ultimate upper bounds for all variables of this model and two lower bounds and, besides, study when dynamics of this model po …
This model was elaborated by Arciero et al. and is obtained from the Kirschner-Panetta type model by introducing two various treatmen …
Panetta eyes cost limits.
Wagner L. Wagner L. Mod Healthc. 1993 Jan 18;23(3):4. Mod Healthc. 1993. PMID: 10123661 No abstract available.
Administration of temozolomide: Comparison of conventional and metronomic chemotherapy regimens.
Houy N, Le Grand F. Houy N, et al. J Theor Biol. 2018 Jun 7;446:71-78. doi: 10.1016/j.jtbi.2018.02.034. Epub 2018 Mar 8. J Theor Biol. 2018. PMID: 29526662
For toxicity, which is measured by the nadir of the normalized absolute neutrophil count, we formalize the myelosuppression effect of temozolomide with the physiological model of Panetta et al. (2003b). We introduce a multi-criteria tool for comparing protocols along their …
For toxicity, which is measured by the nadir of the normalized absolute neutrophil count, we formalize the myelosuppression effect of temozo …
Epihetacillin.
Johnson DA, Mania D, Panetta CA, Silvestri HH. Johnson DA, et al. Tetrahedron Lett. 1968 Feb;16:1903-5. doi: 10.1016/s0040-4039(01)99051-3. Tetrahedron Lett. 1968. PMID: 5645063 No abstract available.
Optimal dynamic regimens with artificial intelligence: The case of temozolomide.
Houy N, Le Grand F. Houy N, et al. PLoS One. 2018 Jun 26;13(6):e0199076. doi: 10.1371/journal.pone.0199076. eCollection 2018. PLoS One. 2018. PMID: 29944669 Free PMC article.
For toxicity, which is measured by the nadir of the normalized absolute neutrophil count, we formalize the myelosuppression effect of temozolomide with the physiological model of Panetta and coauthors (Panetta, et al., 2003). We apply the model to a population with …
For toxicity, which is measured by the nadir of the normalized absolute neutrophil count, we formalize the myelosuppression effect of temozo …
Tumour suppression by immune system through stochastic oscillations.
Caravagna G, d'Onofrio A, Milazzo P, Barbuti R. Caravagna G, et al. J Theor Biol. 2010 Aug 7;265(3):336-45. doi: 10.1016/j.jtbi.2010.05.013. Epub 2010 May 16. J Theor Biol. 2010. PMID: 20580640
The well-known Kirschner-Panetta model for tumour-immune System interplay [Kirschner, D., Panetta, J.C., 1998. ...
The well-known Kirschner-Panetta model for tumour-immune System interplay [Kirschner, D., Panetta, J.C., 1998. ...
Zhao et al. Reply.
Zhao SYF, Poccia N, Panetta MG, Yu C, Johnson JW, Yoo H, Zhong R, Gu GD, Watanabe K, Taniguchi T, Postolova SV, Vinokur VM, Kim P. Zhao SYF, et al. Phys Rev Lett. 2020 Jun 19;124(24):249702. doi: 10.1103/PhysRevLett.124.249702. Phys Rev Lett. 2020. PMID: 32639818 No abstract available.
The safety profile of probiotic VSL#3®. A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials.
Panetta V, Bacchieri A, Papetti S, De Stefani E, Navarra P. Panetta V, et al. Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6443. doi: 10.26355/eurrev_202111_27130. Eur Rev Med Pharmacol Sci. 2021. PMID: 34787844 Free article.
A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials", by V. Panetta, A. Bacchieri, S. Papetti, E. De Stefani, P. Navarra, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 963-973-DOI: 10.26355/eurrev_202001_20082-PMID: 32017 …
A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials", by V. Panetta, A. Bacchieri, S. Pa …
1,035 results